|
Sign In to gain access to subscriptions and/or personal tools.
|
11(3):279-303 (2000) Crit Rev Oral Biol Med
© 2000 SAGE Publications
Osteopontin
J. Sodek
MRC Group in Periodontal Physiology, Faculty of Dentistry, Room 239 Fitzgerald Building, Department of Biochemistry, University of Toronto, 150 College Street, Toronto, ON, Canada M5S 3E2, jaro.sodek{at}utoronto.ca
B. Ganss
MRC Group in Periodontal Physiology, Faculty of Dentistry, Room 239 Fitzgerald Building
M.D. McKee
MRC Group in Periodontal Physiology, Faculty of Dentistry, Room 239 Fitzgerald Building, Faculty of Dentistry and the Department of Anatomy and Cell Biology, McGill University, Montréal, Canada
Osteopontin (OPN) is a highly phosphorylated sialoprotein that is a prominent component of the mineralized extracellular matrices of bones and teeth. OPN is characterized by the presence of a polyaspartic acid sequence and sites of Ser/Thr phosphorylation that mediate hydroxyapatite binding, and a highly conserved RGD motif that mediates cell attachment/signaling. Expression of OPN in a variety of tissues indicates a multiplicity of functions that involve one or more of these conserved motifs. While the lack of a clear phenotype in OPN "knockout" mice has not established a definitive role for OPN in any tissue, recent studies have provided some novel and intriguing insights into the versatility of this enigmatic protein in diverse biological events, including developmental processes, wound healing, immunological responses, tumorigenesis, bone resorption, and calcification. The ability of OPN to stimulate cell activity through multiple receptors linked to several interactive signaling pathways can account for much of the functional diversity. In this review, we discuss the structural features of OPN I hat relate to its function in the formation, remodeling, and maintenance of bones and teeth.
Key Words: Sialoprotein cell signaling cell attachment bone remodeling tooth.
Critical Reviews in Oral Biology & Medicine, Vol. 11, No. 3,
279-303 (2000)
DOI: 10.1177/10454411000110030101

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
L. Schack, A. Lange, J. Kelsen, J. Agnholt, B. Christensen, T. E. Petersen, and E. S. Sorensen
Considerable variation in the concentration of osteopontin in human milk, bovine milk, and infant formulas
J Dairy Sci,
November 1, 2009;
92(11):
5378 - 5385.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y.-C. Chien, D. L. Masica, J. J. Gray, S. Nguyen, H. Vali, and M. D. McKee
Modulation of Calcium Oxalate Dihydrate Growth by Selective Crystal-face Binding of Phosphorylated Osteopontin and Polyaspartate Peptide Showing Occlusion by Sectoral (Compositional) Zoning
J. Biol. Chem.,
August 28, 2009;
284(35):
23491 - 23501.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Schack, R. Stapulionis, B. Christensen, E. Kofod-Olsen, U. B. Skov Sorensen, T. Vorup-Jensen, E. S. Sorensen, and P. Hollsberg
Osteopontin Enhances Phagocytosis through a Novel Osteopontin Receptor, the {alpha}X{beta}2 Integrin
J. Immunol.,
June 1, 2009;
182(11):
6943 - 6950.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. H. Anborgh, S. M. Wilson, A. B. Tuck, E. Winquist, N. Schmidt, R. Hart, S. Kon, M. Maeda, T. Uede, L. W. Stitt, et al.
New Dual Monoclonal ELISA for Measuring Plasma Osteopontin as a Biomarker Associated with Survival in Prostate Cancer: Clinical Validation and Comparison of Multiple ELISAs
Clin. Chem.,
May 1, 2009;
55(5):
895 - 903.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-H. Lee, A. Banerjee, Y. Ueno, and S. K. Ramaiah
Potential Relationship between Hepatobiliary Osteopontin and Peroxisome Proliferator-Activated Receptor {alpha} Expression following Ethanol-Associated Hepatic Injury In Vivo and In Vitro
Toxicol. Sci.,
November 1, 2008;
106(1):
290 - 299.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. J. Caruso, A. J.K. Carmack, V. B. Lokeshwar, R. C. Duncan, M. S. Soloway, and B. L. Lokeshwar
Osteopontin and Interleukin-8 Expression is Independently Associated with Prostate Cancer Recurrence
Clin. Cancer Res.,
July 1, 2008;
14(13):
4111 - 4118.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Kawasaki and K.M. Weiss
SCPP Gene Evolution and the Dental Mineralization Continuum
Journal of Dental Research,
June 1, 2008;
87(6):
520 - 531.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Malaval, N. M. Wade-Gueye, M. Boudiffa, J. Fei, R. Zirngibl, F. Chen, N. Laroche, J.-P. Roux, B. Burt-Pichat, F. Duboeuf, et al.
Bone sialoprotein plays a functional role in bone formation and osteoclastogenesis
J. Exp. Med.,
May 12, 2008;
205(5):
1145 - 1153.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. K. Ramaiah and S. Rittling
Pathophysiological Role of Osteopontin in Hepatic Inflammation, Toxicity, and Cancer
Toxicol. Sci.,
May 1, 2008;
103(1):
4 - 13.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Zhang, J. Zhu, P. Valverde, L. Li, S. Pageau, Q. Tu, R. Nishimura, T. Yoneda, P. Yang, W. Zheng, et al.
Phenotypic Analysis of Dlx5 Overexpression in Post-natal Bone
Journal of Dental Research,
January 1, 2008;
87(1):
45 - 50.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Chakraborty, S. Jain, and G. C. Kundu
Osteopontin Promotes Vascular Endothelial Growth Factor Dependent Breast Tumor Growth and Angiogenesis via Autocrine and Paracrine Mechanisms
Cancer Res.,
January 1, 2008;
68(1):
152 - 161.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Christensen, C. C. Kazanecki, T. E. Petersen, S. R. Rittling, D. T. Denhardt, and E. S. Sorensen
Cell Type-specific Post-translational Modifications of Mouse Osteopontin Are Associated with Different Adhesive Properties
J. Biol. Chem.,
July 6, 2007;
282(27):
19463 - 19472.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. R. Rodrigues, J. A. Teixeira, F. L. Schmitt, M. Paulsson, and H. Lindmark-Mansson
The Role of Osteopontin in Tumor Progression and Metastasis in Breast Cancer
Cancer Epidemiol. Biomarkers Prev.,
June 1, 2007;
16(6):
1087 - 1097.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. N. Addison, F. Azari, E. S. Sorensen, M. T. Kaartinen, and M. D. McKee
Pyrophosphate Inhibits Mineralization of Osteoblast Cultures by Binding to Mineral, Up-regulating Osteopontin, and Inhibiting Alkaline Phosphatase Activity
J. Biol. Chem.,
May 25, 2007;
282(21):
15872 - 15883.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. S Gupta, P. Fratzl, M. Kerschnitzki, G. Benecke, W. Wagermaier, and H. O.K Kirchner
Evidence for an elementary process in bone plasticity with an activation enthalpy of 1 eV
J R Soc Interface,
April 22, 2007;
4(13):
277 - 282.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Martinek, J. Shahab, J. Sodek, and M. Ringuette
Is SPARC an Evolutionarily Conserved Collagen Chaperone?
Journal of Dental Research,
April 1, 2007;
86(4):
296 - 305.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. T. Kaartinen, M. Murshed, G. Karsenty, and M. D. McKee
Osteopontin Upregulation and Polymerization by Transglutaminase 2 in Calcified Arteries of Matrix Gla Protein-deficient Mice
J. Histochem. Cytochem.,
April 1, 2007;
55(4):
375 - 386.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-L. Lee, M.-J. Wang, P.-R. Sudhir, G.-D. Chen, C.-W. Chi, and J.-Y. Chen
Osteopontin Promotes Integrin Activation through Outside-In and Inside-Out Mechanisms: OPN-CD44V Interaction Enhances Survival in Gastrointestinal Cancer Cells
Cancer Res.,
March 1, 2007;
67(5):
2089 - 2097.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Seenundun and B. Robaire
Time-Dependent Rescue of Gene Expression by Androgens in the Mouse Proximal Caput Epididymidis-1 Cell Line after Androgen Withdrawal
Endocrinology,
January 1, 2007;
148(1):
173 - 188.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Jain, G. Chakraborty, and G. C. Kundu
The Crucial Role of Cyclooxygenase-2 in Osteopontin-Induced Protein Kinase C {alpha}/c-Src/I{kappa}B Kinase {alpha}/{beta}-Dependent Prostate Tumor Progression and Angiogenesis.
Cancer Res.,
July 1, 2006;
66(13):
6638 - 6648.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. L. Allan, R. George, S. A. Vantyghem, M. W. Lee, N. C. Hodgson, C. J. Engel, R. L. Holliday, D. P. Girvan, L. A. Scott, C. O. Postenka, et al.
Role of the Integrin-Binding Protein Osteopontin in Lymphatic Metastasis of Breast Cancer
Am. J. Pathol.,
July 1, 2006;
169(1):
233 - 246.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. H.C. Bramwell, G. S. Doig, A. B. Tuck, S. M. Wilson, K. S. Tonkin, A. Tomiak, F. Perera, T. A. Vandenberg, and A. F. Chambers
Serial plasma osteopontin levels have prognostic value in metastatic breast cancer.
Clin. Cancer Res.,
June 1, 2006;
12(11):
3337 - 3343.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Sodek, A. P. Batista Da Silva, and R. Zohar
Osteopontin and Mucosal Protection
Journal of Dental Research,
May 1, 2006;
85(5):
404 - 415.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Ito, Y. Hashimoto, E. Tanaka, T. Kan, S. Tsunoda, F. Sato, M. Higashiyama, T. Okumura, and Y. Shimada
An Inducible Short-Hairpin RNA Vector against Osteopontin Reduces Metastatic Potential of Human Esophageal Squamous Cell Carcinoma In vitro and In vivo
Clin. Cancer Res.,
February 15, 2006;
12(4):
1308 - 1316.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. C. Khodavirdi, Z. Song, S. Yang, C. Zhong, S. Wang, H. Wu, C. Pritchard, P. S. Nelson, and P. Roy-Burman
Increased Expression of Osteopontin Contributes to the Progression of Prostate Cancer
Cancer Res.,
January 15, 2006;
66(2):
883 - 888.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Donati, L. Boldrini, M. Dell'Omodarme, M. C. Prati, P. Faviana, T. Camacci, M. Lucchi, A. Mussi, M. Santoro, F. Basolo, et al.
Osteopontin Expression and Prognostic Significance in Non-Small Cell Lung Cancer
Clin. Cancer Res.,
September 15, 2005;
11(18):
6459 - 6465.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Briese, M. Oberndorfer, C. Patschenik, H. M. Schulte, A. Makrigiannakis, T. Loning, and A.-M. Bamberger
Osteopontin Is Colocalized with the Adhesion Molecule CEACAM1 in the Extravillous Trophoblast of the Human Placenta and Enhances Invasion of CEACAM1-Expressing Placental Cells
J. Clin. Endocrinol. Metab.,
September 1, 2005;
90(9):
5407 - 5413.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Y. Alexander, F. L. Wilkinson, J. P. Kirton, C. F. Rock, G. D.M. Collett, M. Jeziorska, J. V. Smyth, A. M. Heagerty, and A. E. Canfield
Identification and Characterization of Vascular Calcification-Associated Factor, a Novel Gene Upregulated During Vascular Calcification In Vitro and In Vivo
Arterioscler Thromb Vasc Biol,
September 1, 2005;
25(9):
1851 - 1857.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. K. Nilsson, H. M. Johnston, G. A. Whitty, B. Williams, R. J. Webb, D. T. Denhardt, I. Bertoncello, L. J. Bendall, P. J. Simmons, and D. N. Haylock
Osteopontin, a key component of the hematopoietic stem cell niche and regulator of primitive hematopoietic progenitor cells
Blood,
August 15, 2005;
106(4):
1232 - 1239.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Y. Han, N. K. Lee, K. H. Kim, I. W. Jang, M. Yim, J. H. Kim, W. J. Lee, and S. Y. Lee
Transcriptional induction of cyclooxygenase-2 in osteoclast precursors is involved in RANKL-induced osteoclastogenesis
Blood,
August 15, 2005;
106(4):
1240 - 1245.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Reich, N. Jaffe, A. Tong, I. Lavelin, O. Genina, M. Pines, D. Sklan, A. Nussinovitch, and E. Monsonego-Ornan
Weight loading young chicks inhibits bone elongation and promotes growth plate ossification and vascularization
J Appl Physiol,
June 1, 2005;
98(6):
2381 - 2389.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Giacopelli, R. Marciano, A. Pistorio, P. Catarsi, S. Canini, G. Karsenty, and R. Ravazzolo
Polymorphisms in the osteopontin promoter affect its transcriptional activity
Physiol Genomics,
December 15, 2004;
20(1):
87 - 96.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Nanci, R. M. Wazen, S. F. Zalzal, M. Fortin, H. A. Goldberg, G. K. Hunter, and D.-L. Ghitescu
A Tracer Study with Systemically and Locally Administered Dinitrophenylated Osteopontin
J. Histochem. Cytochem.,
December 1, 2004;
52(12):
1591 - 1600.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W.-K. Suh, S. X. Wang, A. H. Jheon, L. Moreno, S. K. Yoshinaga, B. Ganss, J. Sodek, M. D. Grynpas, and T. W. Mak
The immune regulatory protein B7-H3 promotes osteoblast differentiation and bone mineralization
PNAS,
August 31, 2004;
101(35):
12969 - 12973.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Qin, O. Baba, and W.T. Butler
POST-TRANSLATIONAL MODIFICATIONS OF SIBLING PROTEINS AND THEIR ROLES IN OSTEOGENESIS AND DENTINOGENESIS
Critical Reviews in Oral Biology & Medicine,
May 1, 2004;
15(3):
126 - 136.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Harmey, L. Hessle, S. Narisawa, K. A. Johnson, R. Terkeltaub, and J. L. Millan
Concerted Regulation of Inorganic Pyrophosphate and Osteopontin by Akp2, Enpp1, and Ank: An Integrated Model of the Pathogenesis of Mineralization Disorders
Am. J. Pathol.,
April 1, 2004;
164(4):
1199 - 1209.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Komaki, A. Asakura, M. A. Rudnicki, J. Sodek, and S. Cheifetz
MyoD enhances BMP7-induced osteogenic differentiation of myogenic cell cultures
J. Cell Sci.,
March 15, 2004;
117(8):
1457 - 1468.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Kawamura, K. Yokote, S. Asaumi, K. Kobayashi, M. Fujimoto, Y. Maezawa, Y. Saito, and S. Mori
High Glucose-Induced Upregulation of Osteopontin Is Mediated via Rho/Rho Kinase Pathway in Cultured Rat Aortic Smooth Muscle Cells
Arterioscler Thromb Vasc Biol,
February 1, 2004;
24(2):
276 - 281.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
G. A. Johnson, R. C. Burghardt, F. W. Bazer, and T. E. Spencer
Osteopontin: Roles in Implantation and Placentation
Biol Reprod,
November 1, 2003;
69(5):
1458 - 1471.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. A. Furger, A. L. Allan, S. M. Wilson, C. Hota, S. A. Vantyghem, C. O. Postenka, W. Al-Katib, A. F. Chambers, and A. B. Tuck
{beta}3 Integrin Expression Increases Breast Carcinoma Cell Responsiveness to the Malignancy-Enhancing Effects of Osteopontin
Mol. Cancer Res.,
September 1, 2003;
1(11):
810 - 819.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. T. de Oliveira, S. F. Zalzal, K. Irie, and A. Nanci
Early Expression of Bone Matrix Proteins in Osteogenic Cell Cultures
J. Histochem. Cytochem.,
May 1, 2003;
51(5):
633 - 641.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Q.-T. Le, P. D. Sutphin, S. Raychaudhuri, S. C. T. Yu, D. J. Terris, H. S. Lin, B. Lum, H. A Pinto, A. C. Koong, and A. J. Giaccia
Identification of Osteopontin as a Prognostic Plasma Marker for Head and Neck Squamous Cell Carcinomas
Clin. Cancer Res.,
January 1, 2003;
9(1):
59 - 67.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Chellaiah, N. Kizer, R. Biswas, U. Alvarez, J. Strauss-Schoenberger, L. Rifas, S. R. Rittling, D. T. Denhardt, and K. A. Hruska
Osteopontin Deficiency Produces Osteoclast Dysfunction Due to Reduced CD44 Surface Expression
Mol. Biol. Cell,
January 1, 2003;
14(1):
173 - 189.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
W. J. Grzesik and A.S. Narayanan
CEMENTUM AND PERIODONTAL WOUND HEALING AND REGENERATION
Critical Reviews in Oral Biology & Medicine,
November 1, 2002;
13(6):
474 - 484.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Shimazu, A. Nanci, and T. Aoba
Immunodetection of Osteopontin at Sites of Resorption in the Pulp of Rat Molars
J. Histochem. Cytochem.,
July 1, 2002;
50(7):
911 - 922.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. S. Rudland, A. Platt-Higgins, M. El-Tanani, S. de Silva Rudland, R. Barraclough, J. H. R. Winstanley, R. Howitt, and C. R. West
Prognostic Significance of the Metastasis-associated Protein Osteopontin in Human Breast Cancer
Cancer Res.,
June 1, 2002;
62(12):
3417 - 3427.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. C. Luedtke, M. D. McKee, D. G. Cyr, M. Gregory, M. T. Kaartinen, J. Mui, and L. Hermo
Osteopontin Expression and Regulation in the Testis, Efferent Ducts, and Epididymis of Rats During Postnatal Development Through to Adulthood
Biol Reprod,
May 1, 2002;
66(5):
1437 - 1448.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
D. Agrawal, T. Chen, R. Irby, J. Quackenbush, A. F. Chambers, M. Szabo, A. Cantor, D. Coppola, and T. J. Yeatman
Osteopontin Identified as Lead Marker of Colon Cancer Progression, Using Pooled Sample Expression Profiling
J Natl Cancer Inst,
April 3, 2002;
94(7):
513 - 521.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. S. Perrien, E. C. Brown, J. Aronson, R. A. Skinner, D. C. Montague, T. M. Badger, and C. K. Lumpkin Jr.
Immunohistochemical Study of Osteopontin Expression During Distraction Osteogenesis in the Rat
J. Histochem. Cytochem.,
April 1, 2002;
50(4):
567 - 574.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. E. Garlow, H. Ka, G. A. Johnson, R. C. Burghardt, L. A. Jaeger, and F. W. Bazer
Analysis of Osteopontin at the Maternal-Placental Interface in Pigs
Biol Reprod,
March 1, 2002;
66(3):
718 - 725.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. B. C. Apparao, M. J. Murray, M. A. Fritz, W. R. Meyer, A. F. Chambers, P. R. Truong, and B. A. Lessey
Osteopontin and Its Receptor {alpha}v{beta}3 Integrin Are Coexpressed in the Human Endometrium during the Menstrual Cycle But Regulated Differentially
J. Clin. Endocrinol. Metab.,
October 1, 2001;
86(10):
4991 - 5000.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. E. Arana-Chavez and A. Nanci
High-resolution Immunocytochemistry of Noncollagenous Matrix Proteins in Rat Mandibles Processed with Microwave Irradiation
J. Histochem. Cytochem.,
September 1, 2001;
49(9):
1099 - 1110.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Agnihotri, H. C. Crawford, H. Haro, L. M. Matrisian, M. C. Havrda, and L. Liaw
Osteopontin, a Novel Substrate for Matrix Metalloproteinase-3 (Stromelysin-1) and Matrix Metalloproteinase-7 (Matrilysin)
J. Biol. Chem.,
July 20, 2001;
276(30):
28261 - 28267.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|